Max Robotics — Global Service Robot Directory + US Certification

About

Ursula Nestle is a leading radiation oncologist whose research has significantly advanced the treatment of early-stage non-small cell lung cancer (NSCLC), particularly through stereotactic body radiation therapy (SBRT). Her most-cited work, the 2017 "Planning benchmark study for SBRT of early stage NSCLC" (54 citations), established critical quality assurance standards for SBRT planning, helping to harmonize clinical practices across institutions. Nestle's major contributions center on optimizing radiation delivery techniques to improve tumor control while minimizing toxicity to healthy lung tissue. Her research has directly influenced international treatment guidelines for inoperable early-stage NSCLC, demonstrating how precise dose prescription and target volume definition can enhance patient outcomes. Beyond this benchmark study, Nestle has published extensively on functional imaging for radiotherapy planning, integrating PET-CT data to better delineate tumor boundaries. Her work bridges the gap between technical radiation physics and clinical oncology, making her a key figure in the evolution of lung cancer radiotherapy. For students and researchers, Nestle exemplifies how rigorous methodological studies can translate into tangible improvements in cancer care.